Carbapenem-resistant Acinetobacter baumannii contamination in an intensive care unit

Otávio Hallal Ferreira Raro1, Stephanie Wagner Gallo1, Carlos Alexandre Sanchez Ferreira1

  • 1Laboratório de Imunologia e Microbiologia, Faculdade de Biociências, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, RS, Brasil.

Abstract

Insights

The intensive care unit (ICU) environment, including surfaces and staff gloves, is frequently contaminated with multidrug-resistant Acinetobacter baumannii. This highlights the ICU environment as a potential source of hospital-acquired infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Environmental Health

Background:

  • Acinetobacter baumannii is a significant pathogen responsible for infections in intensive care units (ICUs).
  • Understanding the environmental reservoirs of A. baumannii within ICUs is crucial for infection control.
  • The prevalence and antimicrobial resistance patterns of A. baumannii in the ICU environment and from healthcare workers' gloves require investigation.

Purpose of the Study:

  • To determine the presence of Acinetobacter baumannii in the ICU environment and on staff gloves.
  • To characterize the antimicrobial resistance of A. baumannii isolates from the ICU environment.
  • To compare environmental and clinical A. baumannii isolates regarding antimicrobial resistance.

Main Methods:

  • Environmental and clinical samples were collected from an ICU over a nine-month period.
  • Isolates were identified using biochemical tests and PCR targeting 16S rDNA and bla OXA-51 genes.
  • Antimicrobial susceptibility testing (disk diffusion, broth microdilution) and detection of carbapenem resistance genes (bla OXA-23) were performed.

Main Results:

  • Acinetobacter baumannii was detected in 9.5% of environmental samples, with bed rails being highly contaminated.
  • The majority of environmental and clinical isolates were multidrug-resistant (MDR) and showed reduced susceptibility to carbapenems.
  • All carbapenem-resistant isolates harbored the bla OXA-23 gene.

Conclusions:

  • The ICU environment is a significant reservoir for multidrug-resistant Acinetobacter baumannii.
  • Environmental contamination, including on staff gloves, likely contributes to the persistence and spread of MDR A. baumannii in ICUs.
  • The ICU environment may serve as a source for hospital-acquired infections caused by A. baumannii.

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.4K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
538
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
554
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K